SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-210565
Filing Date
2022-08-03
Accepted
2022-08-03 07:23:35
Documents
7
Effectiveness Date
2022-08-03

Document Format Files

Seq Description Document Type Size
1 S-8 d378309ds8.htm S-8 33278
2 EX-5.1 d378309dex51.htm EX-5.1 38259
3 EX-23.2 d378309dex232.htm EX-23.2 1514
4 EX-FILING FEES d378309dexfilingfees.htm EX-FILING FEES 18058
5 GRAPHIC g378309dsp01.jpg GRAPHIC 12286
6 GRAPHIC g378309dsp01a.jpg GRAPHIC 3472
7 GRAPHIC g378309dsp01b.jpg GRAPHIC 46387
  Complete submission text file 0001193125-22-210565.txt   178389
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266479 | Film No.: 221130917
SIC: 2834 Pharmaceutical Preparations